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 INTRODUCTION 
 Gastric Carcinoma, one of the oldest disease which dates back to 
980-1037 BC. Aricena was the great person who gave first inputs 
regarding  Gastric carcinoma. In 1761 Morgagni, was the person, who 
provided elaborate findings related to carcinoma stomach. Passing through 
the years, it has become, one the leading cause which contributes to death 
across the world. 
 The various reviews across the world now states that gastric 
malignancy is on declining pattern but, in India malignancy of stomach 
still a major factor which has an impact over low income and people who 
are below poverty line.So this study was chosen to find out the various 
factors which will affect the occurrence of Gastric cancer 
 Malignancies related stomach has maximum occurrence among 
southeast Asian countries. Among these, Japan bears the major brunt. This 
may be mainly due their food habits, radiation, obesity. In India, Gastric 
carcinoma is one the leading disease which causes morbidity and 
mortality. North-eastern states, especially Mizoram is the leading 
contender in occurrence of carcinoma stomach. 
 The main contributing factors for the increased incidence of gastric 
cancer will be food habits and environmental factors. Among food habits, 
  
having salt content more in food and, increased consumption of grilled 
foods are the major determinants. In the environmental factors  smoking, 
alcohol consumption, tobacco chewing are the main culprits for the 
occurrence of gastric malignancy 
 The etiopathogenesis  of  gastric  malignancy  will  be  mainly  
related  to interaction between  genetic  and  environmental  factors. Diet  
and  H.pylori will  be  the  major  contributing  factors   with  regarding  to 
environmental  causes. With  recent  advancements  in  molecular  biology  
enlights  us,  the  concealed  facts  regarding  genomic  association  of  
gastric  malignancy.      Over expression  of  abnormal  genes  and  .lack  
of  heterogenisity in  tumour  suppressor  genes are  the  important   factors 
with  genetic  association 
           Among  the  types   of  gastric  malignancy   adenocarcinomas   
predominates. The  rest  of  the  types  will  be  lymphoma  and  stromal  
tumours. Adenocarcinoma  has  two  histological  types. Well 
differentiated  or  diffuse  type  and  intestinal  or  undifferentiated  types. 
          The  morbidity  and  mortality  related  to  gastric  malignancies  is  
mainly  related  to  the  time   when  the  patient  comes  to  the  hospital. 
Early  detection  and  intervention  will increase  the  five  year  survival 
rate. 
  
AIMS AND   OBJECTIVES OF THE   STUDY 
1. To study the prevalence of   carcinoma   stomach as occurring   in  
Tirunelveli Medical College Hospital. 
2. To find out the  etiology and risk factors for   carcinoma stomach 
3 To study the presenting   clinical signs and symptoms of carcinoma 
stomach 
4. To  study  the  anatomical  location  of  carcinoma   stomach  with   
respect   to  the  age  and  sex 
5. To analysize  the   histopathological   type  in  relation  to  the  site   
 growth  and  age  of  the  patient 
6. To   study   the surgical   modalties  of   treatment. 
 
 
 
 
 
 
 
 
 
  
REVIEW OF LITERATURE 
Gastric malignancy is one of the leading cause of cancer related 
deaths. Its prognosis tends to be poor with cure rates little better than       
5–10%, although better results are obtained in Japan where the disease is 
common. Gastric cancer is actually an eminently curable disease provided 
that it is detected at an appropriate  stage and treated adequately. It rarely 
disseminates widely before it has involved the lymph nodes and, therefore, 
there is an opportunity to cure the disease prior to dissemination. Early 
diagnosis is therefore the key to success. Unfortunately, the late 
presentation of many cases is the cause of the poor overall survival figures. 
The only treatment modality able to cure the disease is resectional surgery. 
The occurrence of gastric cancer differs across the world. Various 
countries showed different datas with relation to its incidence. Of these 
Japan is the forerunner in terms of cases per one lakh population. It closely 
comes around 70 cases/population/year .Other western countries has lesser 
incidence rates when compared to japan.Eastern European countries and 
China closely matches japan in terms of occurrence of gastric cancer. 
 In India, the occurrence of gastric malignancy varies region wise. 
According to the National Cancer Register, North eastern states has the 
maximum number of population with gastric cancer. It has surpassed 
  
Kashmir,in terms of incidence. Among north ,south difference ,south 
Indian population are more vulnerable to have gastric cancer. This may be 
due to diet related factors, which play a major role.        
The occurrence of gastric cancer differs across the world. In general, 
men are more affected by the disease than women and, as with most solid 
organ malignancies, the incidence increases with age. At present, marked 
changes are being observed in the developed countries in terms of the 
occurrence and sites of gastric malignancy and the population affected, 
changes that to date have not been observed in Japan. First, the incidence 
of gastric cancer is continuing to decrease, at a rate of about one 
percentage per year, with the reduction exclusively affect in carcinomas 
arising in the body of the stomach and the distal stomach. In contrast, the 
incidence of carcinoma in the proximal stomach, particularly the 
oesophagogastric junction, appears to be increasing .Malignancy occurring 
in  the distal  and body of the stomach is most common in low income 
groups, whereas the increase in proximal gastric cancer seems to affect 
principally the people belonging to the higher income group . Proximal 
gastric cancer does not seem to be associated with H. pylori infection, in 
contrast with cancer affecting  the body and the distal stomach. 
 
  
HISTORY 
1875 Sidney Jones in London publishes the first successful gastrostomy 
for feeding. 
1879 Paen performed distal gastrectomy and gastroduodenostomy. The 
patient died 5 days later. 
1880 Rydygier ressected a distal gastric cancer, and the patient died 12 
h later. 
1880 Billroth ressects distal gastric cancer and performs 
gastroduodenostomy (Billroth I).  
1881 Anton Wolfler performs loop gastrojejunostomy to palliate an 
obstructing distal gastric cancer. 
1884 Rydygier reports an unsuccessful gastrojejunostomy for benign 
gastric outlet obstruction. 
 1885 Billroth performs a successful distal gastrectomy and 
gastrojejunostomy (Billroth II) for gastric cancer 
1980–2000 Japanese surgeons and other surgical groups from East Asia 
demonstrate that more aggressive lymphadenectomy may improve 
survival in patients with gastric cancer. 
1990–current Evolving role of laparoscopic techniques in the treatment of 
surgical gastric disease 
  
ANATOMY OF STOMACH 
 Development: The  caudal  part  of  foregut  shows  a  fusiform  
dilation  with anterior and posterior borders,along with right/left surfaces, 
This partiscalled stomach.It  rotates  90 degree  clockwise,so  that  left  
surface  faces  anteriorly.the  posterior  border  of  stomach  grows  faster 
,forming  the  greater  curvature. 
 The  stomach  rotates  anteroposterior  axis  ,so  that  distal  or  
pyloric  part  moves  to  right and  proximal  or  cardiac  part  moves  to  
left  side. 
 The  90  degree  rotation  of  stomach  along  the  vertical  axis  pulls  
the  dorsalmesogastrium  to  the  left  and  forming  the  lesser  sac  or  
omental  bursa. 
The embryologist describes the stomach as a fusiform dilatation of 
the foregut, beginning at the gastroesophageal junction and ending at the 
gastro duodenal junction. 
The anatomist describes the stomach in terms of its several parts, 
such as the gastroesophageal junction, cardia, fundus, body, antrum, 
pyloric canal, and sphincter, but also accepts the stomach as a distinct 
entity, a well-defined organ that is easily visualized, dissected, and 
demonstrated.  
  
The physiologist and gastroenterologist describe the endocrine and 
exocrine stomach, treating the organ as two units, proximal and distal:    
Proximal stomach - The proximal stomach (fundus and body)  
receives and temporarily stores gastric contents. It is the home of the 
parietal cells which secrete acid and intrinsic factors, as well as the home 
of the cells that produce Group 1 pepsinogen. 
Distal stomach - The distal stomach (antrum and pylorus) mixes 
and propels the gastric contents. It also contains the area of the pyloric 
glands which produce the hormones gastrin and somatostatin. 
 The distal stomach  and pylorus are likely to reveal vital inhibitory 
mechanism in the regulation of gastrointestinal movement; . 
The pathologist recognizes three subdivisions of the stomach: the 
fundus, body, and antrum. These provide the basis for descriptions of 
localized gross pathology. 
The radiologist, in practical terms, locates the gastroesophageal 
junction just "below the junction," and refers to the first part of the 
duodenum as the duodenal bulb.  
With reference to surgery, stomach was divided  into proximal 
gastric unit and distal gastric  unit. The proximal unit comprises of upper  
stomach, distal oesophagus and  diaphragmatic  hiatus. 
  
The  distal  unit  includes  antrum, pylorus , along  with  the  first  
part  of  the  duodenum. 
PROXIMAL GASTRIC SURGICAL UNIT 
The  proximal gastric unit consists of the distal esophagus, 
esophageal hiatus, and proximal stomach. The esophagus joins the 
stomach in the abdomen, just below the diaphragm. The length of the 
abdominal esophagus is from 0.5 to 2.5 cm 
The abdominal esophagus lies at the level of the 11th or 12th 
thoracic vertebra, perhaps lower in tall, asthenic subjects, and higher in 
short subjects.
31
 Its relationships to surrounding structures are: 
Anterior: Posterior surface of left lobe of liver 
 Posterior: Right crus of diaphragm, aorta 
 Right: Caudate (spigelian) lobe of liver 
 Left: Fundus of stomach 
Relations of the Proximal Gastric Surgical Unit 
The proximal gastric surgical unit has relationships with the lesser 
and greater curvatures, the upper part of the lesser sac (omental bursa), and 
the gastroesophageal (G-E) junction.  
  
 The lesser curvature of the body, the G-E junction, and the 
abdominal esophagus are attached to the hepatogastric ligament and its 
contents. 
The greater curvature attaches to the upper part of the greater 
omentum and the several related splenic ligaments. The anatomic entities 
of the G-E junction will be found in the chapter on the esophagus.  
DISTAL GASTRIC SURGICAL UNIT 
Gastric Antrum 
In the opened stomach, the antrum is easily distinguished from the 
body of the stomach by its mucosa, which is flatter and without rugae. The 
antrum  begins just distal to the termination of the gastric canal.It is also 
histologically distinct, being without chief or parietal (acid-producing) 
cells. The margin of the antrum is irregular, but definite. Externally, the 
antrum is difficult to demarcate 
Pylorus 
The pylorus is a region of the stomach variously called the pyloric 
canal, pyloric ring, and pyloric valve. Proximally, it merges into the gastric 
antrum without a definite external boundary; distally, it ends abruptly at 
the thin-walled duodenum. At its narrowest point, the luminal diameter 
  
never exceeds 19 mm. The size is important in estimating the optimal size 
of artificial openings, such as in gastrojejunostomies or pyloroplasties. 
At the pyloroduodenal junction, the continuity of the circular 
musculature is interrupted by an anular septum that arises from the 
connective tissue of the submucosa. Proximal to this ring, the circular 
muscle layer is thickened to form the pyloric sphincter. Distal to the ring, 
the circular muscle coat at the duodenum is thinner. The sudden decrease 
in wall thickness as one passes from the pylorus to duodenum results in an 
"os pylorus," surrounded by a duodenal "fornix." The existence of this 
fornix must be kept in mind when performing pyloromyotomy 
The lesser curvature of the antrum, the pylorus, and the upper border of 
the duodenum are attached to the hepatogastric and hepatoduodenal 
ligaments (lesser omentum). The greater curvature is attached to the 
gastrocolic ligament (greater omentum). 
Relations of the Distal Gastric Surgical Unit 
The lesser curvature of the antrum, the pylorus, and the upper border 
of the duodenum are attached to the hepatogastric and hepatoduodenal 
ligaments (lesser omentum). The greater curvature is attached to the 
gastrocolic ligament (greater omentum). 
 
  
Posterior relations: 
Floor of lesser sac 
Transverse mesocolon 
Head and neck of pancreas 
Aorta and celiac trunk and its branches 
Celiac ganglion and plexus 
Hepatic triad 
Gastroduodenal artery 
Anterior relations: 
 Anterior abdominal wall 
 Medial segment of left lobe and anterior segment of right lobe of liver 
 Transverse mesocolon 
 Neck of gallbladder (if stomach is empty) 
PROXIMAL UNIT: 
The  proximal gastric unit consists of the distal esophagus, 
esophageal hiatus, and proximal stomach. The esophagus joins the 
stomach in the abdomen, just below the diaphragm. The  abdominal  
oesophagus  measures  about  2.5cm. 
Blood supply of Stomach: 
 Stomach has a rich bloodsupply mainly through celiac plexus. 
  
The four main arteries which has the blood supply will be 
 1.left gastric- largest branch from celiac trunk 
 2.Right gastro epiploic – from gastroduodenal artery 
 3.Left gastroepiploic –branch from splenic artery 
 4.Right  gastric –from hepatic artery 
 The above mentioned vessels along with others form an  anastomotic  
network which travels to both curvatures of stomach .The left and right 
gastric artery passes along greater curvature and both the gastro epiploic 
vessels accompanies along the border of lesser curvature. 
Venous drainage: The stomachs venous system has the following 
veins: 
 Left Gastric (Coronary) Vein 
 Right Gastric Vein 
 Right Gastroepiploic Vein 
 Left Gastroepiploic Vein 
 Left Inferior Phrenic Vein 
 Short Gastric Veins 
 
Lymphatic Drainage   
  
Lymphatics  of  proximal  half  of  stomach  of  stomach  drains  into  
left  gastric, splenic, and superior pancreatic  lymph  nodes. From antrum  
it  drains  into  right  gastric, right  gastroepiploic and  subpyloric  lymph. 
Nodes. From  the  pylorus  ,it drains into right gastric and subpyloric 
nodes.   
  Efferent  lymphatics  from  suprapyloric  region  drains  into  para  
aortic  lymph  nodes  and  into  left  supraclavicular  nodes. Efferent  
lymphatics  from  subpyloric  lymph  nodes  into superior  mesenteric  
lymph  nodes. Lymphatics  near  oesophagogastric junction  communicates  
with  oesophageal  lymphatics. In  carcinoma  stomach  if  upper  
lymphatics  blocked, reterograde  spread  through  lower  lymphatics  
occur.  In  carcinoma  stomach  different  resections  are  classified  as  
RO,R1,R2.,R3 or  D1.D2  Based on  the  levels  of  lymph  nodes in  the  
abdomen   in  relation  to  the stomach.R0  is  no  residual  disease.R1 is  
microscopic  residual  disease. R2  is  Macroscopic  residual  disease. R3  
is  inoperable. Zone 1  lies  in  gastrocolic  omentum  along  the  right  
gastroepiploic vessels, draining  pyloric  portion  of  the  greater  curve  to 
pyloric, coeliac  and  aortic  lymph  nodes.  
  
Zone  2  lies   in  gastrocolic  and  gastrosplenic  omentum  along  
the  left  gastoepiploic  vessels draining  from  upper  half  of  greater  
curve  to  pancreaticosplenic  and  aortic  lymph  nodes. 
Zone 3  is  drainage  from  proximal  two  thirds  of  the  stomach and the  
upper  lesser  curve  along  the  left  gastric  artery. And  drains  into  
perioesophageal  lymph  nodes. 
Zone  4  is  from  distal  portion  of  lesser  curve  and  pylorus along  
hepatic  artery  into  para aortic  lymph  nodes. 
 
LYMPH NODE STATION 
 1  Right paracardial 
 2  Left paracardial 
 3  Lesser curvature 
4sa  Short gastric 
4sb  Left gastroepiploic 
4d  Right gastroepiploic 
5  Suprapyloric 
6  Infrapyloric 
7  Left gastric artery 
8a  Anterior comm. hepatic 
  
8p  Posterior comm. hepatic 
9  Celiac artery 
10  Splenic hilum 
11p  Proximal splenic 
11d  Distal splenic 
12a  Left hepatoduodenal 
12b,p  Posterior hepatoduodenal 
13  Retropancreatic 
14v  Superior mesenteric vein 
14a  Superior mesenteric artery 
15  Middle colic 
16al  Aortic hiatus 
16a2,b1 Para-aortic, middle 
16b2  Para-aortic, caudal 
 
 
 
 
 
 
  
 
Lymphnode Station 
 
 
 
 
 
 
 
 
 
 
  
Lymphatic Drainage of Stomch 
 
 
 
 
 
 
 
 
 
 
  
Gastric Innervation 
Two nerve plexuses, the submucosal or Meissner and the myenteric 
or Auerbach plexus, represent "a brain within the gastrointestinal tract." - 
Elder and Deakin
 
The  above  statement  was  true  because  stomach  has  both  forms  
of  nerve  supply. They are  intrinsic  and  extrinsic  pathways .Both are 
independent of the other and they play pivotal role in both secretory as 
well as motor functions. Both the right and left vagus nerves provides the 
external parasympathetic nerve supply of the stomach. The important 
neurotransmitter is the acetylcholine. The pathway of the vagus nerve 
starts from the nuclei belongs to the nerve, which is present in the floor of 
the fourth ventricle. From there, it passes through the carotid sheath in the 
neck. It enters the mediastinum andhereit gives off recurrent laryngeal 
nerve. Further it divides into several branches which winds around 
esophagus, and here only it forms right and left vagus nerves. 
Near the Gastro Esophageal junction the anterior vagus sends a 
branch (or branches) to the liver in the gastrohepatic ligament, and 
continues along the lesser curvature as the anterior nerve of Latarjet. 
Similarly, the posterior vagus sends branches to the celiac plexus and 
continues along the posterior lesser curvature. The nerves of Latarjet send 
  
segmental branches to the body of the stomach before they terminate near 
the angularis incisura as the "crow's foot," sending branches to the 
antropyloric region.  
 In 50% of patients, there are more than two vagal nerves at the 
esophageal hiatus. The branch that the posterior vagus sends to the 
posterior fundus is termed the criminal nerve of Grassi. This branch 
typically arises above the esophageal hiatus and is easily missed during 
truncal or highly selective vagotomy (HSV). Vagal fibers originating in 
the brain synapse with neurons in Auerbach's myenteric plexus and 
Meissner's submucosal plexus. Although clinicians are accustomed to 
thinking about the vagus nerves as important efferent nerves (i.e., carrying 
stimuli to the viscera), it is important to consider the fact that fully 75% of 
the axons contained in the vagal trunks are afferent (i.e., carrying stimuli 
from the viscera to the brain). 
The extrinsic sympathetic nerve supply to the stomach originates at 
spinal levels T5 through T10 and travels in the splanchnic nerves to the 
celiac ganglion. Postganglionic sympathetic nerves then travel from the 
celiac ganglion to the stomach along the blood vessels. Neurons in the 
myenteric and submucosal plexuses constitute the intrinsic nervous system 
  
of the stomach. There may be more intrinsic gastric neurons than extrinsic 
neurons, but their function is poorly understood. 
Nerve Supply of Stomch  
 
 
Histology 
Knowing  the histology  of  the  stomach  is  important  because  the  
varius  histological  types of  gastric  malignancy  plays  a role  in  
prognosis. Stomach  wall  has  four  vital  layers. The  first  one  is  
  
mucosa,then submucosa, latter muscularis  propria  follows. Lastly  the  
submucosa  forms  the  final  layer. 
The  mucosa  has  epithelium  ,  lamina  propria.and  muscularis  
mucosa.The  lining  epithelium  of  the  stomachs  inner  layer  is  
columnar  epithelium. This  columnar  epithelium  is  of  different  types. 
The  lamina propria  is  an  important  layer. It lies  underneath  the  
basement  membrane. It  contains  blood  vessels, along  with  nerve  
fibres, inflammatory  cells, and  few  connective  tissue. 
Next  part  in  the  mucosa  is  muscularis  mucosa, which  comes  
under  lamina  propria. It  is a thin  mucosal  layer  and  it  forms  the  
deepest  boundary  guts  mucosal  layer. 
The  stomach  has  a  epithelial  lining  of  different  types, which  
varies  according to  the  site. The  main  epithelial  lining  is  with  
columnar  and  glandular. When  the  gastric  mucosa  was  analysed  using  
electro micrograph, it  has  openings  of  gastric  glands. Various  types  of  
epithelial  cells  will  have  the  lining  over  the  gastric  glands. 
The  main  constituents  of  gastric  glands  is  the  endocrine  cells. 
These  cells  constantly  gets  denuded  and  replenished. The  important  
cell  type  is  mucus  secreting  cells, which  are  called  surface epithelial  
cells. It  is  deeply  rooted  into  the  gland  pits and  it  secrete  
  
bicarbonate. This  secretion  of  bicarbonate  protects  the  stomach  from  
getting  injured  by  the  acids, pepsin and  other  irritants  
Intrinsic Gastric Innervation: 
    The  intrinsic  gastric  innervations  of  the  stomach  is related  to  its  
physiological  role. Various  gastric  functions  is  regulated  by  hormonal  
and  neural  methods. The hormonal  mediators  controls  the  stomachs  
functions  by  endocrine, paracrine and  neurocrine  ways. 
   Gastric  acid  secretion  is  mainly  regulated  by  the  following  
enzymes. They  are  acetlcholine, histamine and  gastrin. Among  these  
acetylcholine  is  the  main  mediator, which  is  released  through  vagal  
para  sympathetic  cells 
      The  vagus  nerve  innervates  parietal, G cells and  enterochromaffin 
like    cells. Gastrin  and  cholecystokinin (CCK) receptors  are  present  in 
parietal  cells. Muscarinic  receptors  and  its  M3  type  acts  as  a 
mediator  for acetylcholine. Histamine  receptor, H 2  subtype  produces  
histamine  like  effect. The  other  receptors  will  be  somatostatin  
receptor and  secondary  messengers  like  cyclic  AMP  and  calcium. 
Gastric  Physiology: 
            The  main  gastric  functions  are  gastric  acid  secretion, 
maintenance  of  gastric  Ph,gastric  motility..Gastric  acid  secretion  is  
  
regulated  by  acetylcholine, histamine  and  gastrin. The  basal  acid  
secretion  is      ten     percentage   of  maximal  acid  output. It  is reduced  
by  ninety  percentage  by  after  vagotomy  or  H2  receptor  blockage. 
   The  phases  of  gastric  secretion  are  cephalic  phase,  gastric  phase, 
and  intestinal  phase. The  cephalic  phase  is stimulated through smell 
,sight, taste   and  muscarinic  receptors. The  gastric  phase  is  stimulated  
through food  enters  the  stomach. The  intestinal  phase  is  mediated  by  
chime  entering  the  small  bowel. 
    The  luminal  gastric  pH  is  2.The  pH   at  surface  epithelial  cells  is 
7.These  cells  secrete bicarbonate continuously  into  the  lining  mucous  
gel.  It  keeps  the  pH  of  surface  mucous  at  5.Bicarbonate  in  mucous  
barrier  reduces  luminal  acidity. 
               The  functions  of  gastric  acid  is  conversion  of  pepsinogen  to  
pepsin. It  hydrolyses  proteins  into  polypeptides. It  will  promote the 
release  of  duodenal  secretion  and  prevents  bacterial  colonisation  of  
upper  gastro  intestinal  tract. It  helps  formation  of  food  chyme. 
      The  gastric  juice  contents  are  hydrochloric acid, mucus, swallowed  
saliva, reflux  content  from  duodenum. Parietal  cells  secrete  
electrolytes  and  intrinsic  factor. It is  muco protein.It is  essential  for  
absorption  of  vitamin  B12  in  ileum. Its  secretion  is  independent  of  
  
acid secretion  from  parietal  cells. Pepsinogen  is  a proteolytic  enzyme. 
There  are  two  types  of  cells    secreted  by  chief  cells. They  are  type  
1  and  2.Type  1  is  produced  only  in  stomach. Type  2  is  secreted  
from  surface  epithelial  cells  of  entire  stomach  and  proximal  
duodenum. Mucus  is  secreted  by  surface  mucus  cells  and  mucus  
neck  cells  from  acid  secreting  area  of  stomach  and  antrum. Gel  like  
mucous  contains  contains  85%  water  and  15%  glycoproteins. It  
contains  bicarbonate  secreted  from  the  surface  epithelial  cells. Mucus  
is  strong  gastric  barrier. Mucus  secretion  is  inhibited  by  
anticholinergics. H.pylori  break  the  mucin. 
                The  gastric  motility  is  begins  from  pace maker  cell  of  
cajal. It  is  located  at  proximal  stomach. Special  myoelectric migrating  
complex  slow  waves  with  electric  spikes  maintain  gastric  motility  in  
three  phases. Immediately  after  food  intake  resting  tone  of  fundus  
and  proximal  stomach decrease  causing  receptive  relaxation  and  
gastric  accommodation  mediated  by  vagus.                  
Etiology of Gastric Malignancies: 
There are  umpteen number etiologies postulated  with relation to 
Gastric cancer. Of these environmental, occupational ,food related causes 
  
predominates Others will be smoking and tobacco related causes, 
overweight, consumption of alchohol contributes to lesser extent. 
The risk factors are mentioned below: 
1. Low intake of fresh vegetables,fruits comes under dietary habit 
risk factor 
2. Excessive consumption of red meat,smoked foods also a risk 
factor. 
3. Consuming diets which are rich in nitrosoamines and lead. 
4. Viral infections like Ebstein Barr infection 
5. Economic status also has an impact over site preference Distal 
site is involved in lower income group and proximal in affluent 
society. 
Some precancerous lesions are mentioned below: 
1) Chronic gastritis 
2) Patients with pernicious anemia 
3) H.pylori infection 
4) Polyp of adenomatous orgin which is more than 2cm 
5) Patients having benign gastric ulcer, agammaglobulinemia, 
6) History of previous gastricsurgery 
7) Menetriers disease 
  
Genetic factors: 
      Most  gastric  tumours  are  aneuploid. The  familial  type  was  ten  
percentage. Napolean  and  many  members  of  his  family  died  of  
carcinoma  stomach. Familial  gastric  cancer  is  associated  with  
mutation  of  E-cadherin  gene. It  causes  hereditary  diffuse  gastric  
cancer. Relatives  of  such  family  shows  mutation  of  this  gene. 
Inactivation of  p53, over expression  of  growth  factors, BCL  2  gene  
mutation  are  other  genetic  causes. 
Blood  group  a:  
            A  ‘is  more  susceptible  for  carcinogens. Diffuse  type. It  is  due  
to different  mucopolysaccharide  secretion  in  stomach  of  blood  group  
A  patients. 
Ebstein  barr  virus: 
      It  infects  gastric  epithelial  cells. These  tumours  have  prominent  
lymphoid  stroma. 
Environmental  and  dietary  factors: 
          These  factors  are  of greater  importance. Smoked  food  contains  
polycyclic  hydrocarbons  which  are  carcinogens. The  widespread  use  
of  refrigeration shows  decline  in  the  incidence  of  tumour  in  united 
states. 
  
              Among the dietary habits, spicy food along with high intake of 
salt in food are the major determinants in occurrence of gastric 
malignancy. 
      In  atrophic  gastritis and  achlorhydria  ,stomach  predispose  to the  
production  of  N-nitroso  carcinogens. High  gastric p H  promote  
bacterial  overgrowth  in  the  stomach. The  organisms  converte  the  
nitrites  to  carcinogenic  nitrogens. Defect in  the  mucosal  barrier  
facilitate  the  penetration  of  carcinogens. Cigarette  smoking  ,alcohol  
have  increased  risk. Increased  concentration  of  zinc  and  lead  in  
drinking  water  have  increased  risk. 
  The  occupational  causes  are  rubber  workers  and  coal  workers. 
Zinc, lead. talc .and  asbestos  cause  carcinoma  stomach. High  
consumption  of  fruits  have  low  incidence  of  gastric  cancers. Fruits  
and  vegetables  rich  in  vitamin  C  protect  from  carcinoma  stomach. 
 
 
Predisposing Conditions 
Polyps 
There are five types of gastric epithelial polyps: inflammatory, 
hamartomatous, heterotopic, hyperplastic, and adenoma. The first three 
  
types have negligible malignant potential. Adenomas can lead to 
carcinoma, just like in the colon, and should be removed when diagnosed. 
Occasionally, hyperplastic polyps can be associated with carcinoma. 
Patients with familial adenomatous polyposis have a high prevalence of 
gastric adenomatous polyps(about 50%), and are 10 times more likely to 
develop adenocarcinoma of the stomach than the general population. 
Screening EGD is indicated in these families. Patients with hereditary 
nonpolyposis colorectal cancer may also be at risk for gastric cancer. 
Atrophic Gastritis 
Chronic atrophic gastritis is by far the most common precursor for 
gastric cancer, particularly the intestinal subtype The prevalence of 
atrophic gastritis is higher in older age groups, but it is also common in 
younger people in areas with a high incidence of gastric cancer. In many 
patients, it is likely that H.pyloriis involved in the pathogenesis of atrophic 
gastritis. Correa described three distinct patterns of chronicatrophic 
gastritis: autoimmune (involves the acid-secreting proximal stomach), 
hypersecretory (involving the distalstomach), and environmental 
(involving multiple random areas at the junction of the oxyntic and antral 
mucosa).  
Intestinal Metaplasia 
  
Gastric carcinoma often occurs in an area of intestinal metaplasia. 
Furthermore, an individual's risk of gastriccancer is proportional to the 
extent of intestinal metaplasia of the gastric mucosa. These observations 
strongly suggest that intestinal metaplasia is a precursor lesion to gastric 
cancer. There are different pathologic subtypes ofintestinal metaplasia in 
the stomach, based upon the histologic and biochemical characteristics of 
the changedmucosal glands. In the complete type of intestinal metaplasia, 
the glands are completely lined with goblet cells and intestinal absorptive 
cells. These cells are indistinguishable histologically and biochemically 
from their small bowel counterparts, and are not seen in the normal 
stomach. There is evidence that eradication of H. Pylori infection leads to 
significant regression of intestinal metaplasia and improvement in atrophic 
gastritis. Therefore,treatment of H. pyloriinfection is a reasonable 
recommendation for patients with these pathologic diagnoses and H.pylori 
infection. 
 
Benign Gastric Ulcer 
Although once considered a premalignant condition, it is likely that 
the older literature was confounded bymistakenly labeling inadequately 
biopsied ulcers and healing ulcers as "benign," when, in fact, they were 
  
malignantto begin with. It is now generally recognized that all gastric 
ulcers are cancer until proven otherwise with adequatebiopsy and follow-
up. Even today, carcinomas are occasionally found when adequately 
biopsied "benign" ulcers areresected for nonhealing. It is more than likely 
that the factors just discussed above are more significant etiologically in 
the development of gastric cancer than the history of a benign gastric 
ulcer. 
 
Gastric Remnant Cancer 
It has long been recognized that stomach cancer can develop in the 
gastric remnant, usually years following distalgastrectomy for PUD. The 
risk is controversial, but the phenomenon is real. Most tumors develop >10 
years following the initial operation, and they usually arise in an area of 
chronic gastritis, metaplasia, and dysplasia. Thisis often near the stoma, 
but many of these tumors are quite large at presentation, and are equally 
divided between intestinal and diffuse subtypes. Most cases have been 
reported following Billroth IIgastroenterostomy, but there also have been 
cases following Billroth I gastroduodenostomy. Whether simple loop 
gastrojejunostomy increases apatient's risk of gastric cancer, and whether a 
Roux-en-Y anastomosis following gastric resection lowers their riskof 
  
gastric cancer is unknown. Stage for stage, the prognosis for gastric stump 
cancer is similar to proximal gastric cancer. 
Other Premalignant States 
A mutated E-cadherin gene is associated with hereditary diffuse 
gastric cancer. Prophylactic total gastrectomyshould be considered. 
Obviously, a myriad of genetic and environmental factors will affect 
members of the same family, and up to 10% of gastric cancer cases appear 
to be familial without a clear-cut genetic diagnosis. First degree relatives 
of patients with gastric cancer have a two- to threefold increased risk of 
developing the disease. Patients with hereditary non polyposis colorectal 
cancer have a 10% risk of developing gastric cancer, predominantly the 
intestinal subtype. The mucous cell hyperplasia of Mntrier's disease is 
generally considered to carry a 5 to 10% risk of adenocarcinoma. Periodic 
surveillance EGD is prudent in all the above conditions. The glandular 
hyperplasia associated with gastrinoma is not premalignant, but ECL 
hyperplasia and/or carcinoid tumors can occur. 
Pathology: 
The main pathological changes found in carcinoma stomach are 
dysplasia, which then leads onto early gastric cancer. It is a well known 
fact  that  gastric dysplasia is a forerunner of malignancy. Patients with 
severe dysplastic changes should be considered for gastric resection, if the 
  
abnormality is wide spread or multifocal. Patients with mild dysplasia 
should be followed with endoscopic surveillance and Helicobacter 
eradication. 
Early Gastric Cancer: 
Early gastric is defined as adenocarcinoma which is confined to the 
mucosa and submucosa, regardless of  lymphnode status. Varioous 
references states that approximately 10% of patients with gastric cancer 
will have lymph node metastases. Regarding types,there are several types 
and subtypes based on morphology and histology. The Japanese 
classification on early gastric cancer is based on morphology. They are 
protruded, superficial and excavated. Approximately 70% of early gastric 
cancer are well differentiated and remaining 30% are poorly differentiated 
 
 
 
Other morphological and histological subtypes: 
The main types of gastric malignancy with relation  to morphology 
will be  -polypoid 
  -fungating 
  -ulcerstive 
  
  -scirrhous 
In the first two, bulk of the tumor mass intraluminal. Polypoid 
tumors are not ulcerated, fungating tumors are elevated intraluminally. In 
the later two gross subtypes, the bulk of the tumor mass is in the wall of 
the  stomach. Ulcerative masses closely resembles ulcers. Scirrhous type 
penetrates the full thickness of the stomach. Scirrhous tumors or Linitis 
plastica have a poor prognosis. 
Histological types: 
The histological classification in gastric malignancies are 
important,in relation to prognosis. There are many types based on 
histology. Of these Laurens classification is commonly used. It classifies 
gastric cancer into three types intestinal, diffuse and unclassified. The 
intestinal type which accounts for about 53%,has got favourable prognosis. 
This type usually associated with chronic atrophic gastritis, severe 
intestinal metaplasia and dysplasia, tends to be less aggressive than the 
diffuse type. The diffuse type which is of 33%,has poor prognosis are 
common young females. This type is usually poorly differentiated with 
early gastric wall invasion, also having both submucosal and subserosal 
lymphatic spread.The last one ,unclassified type tends to be less aggressive 
than diffuse one. 
  
WHO classification based on histology: 
 This classification is based upon histological types of gatric 
carcinoma. 
  1. Adenocarcinoma  -Most common 
   -papillary adenocarcinoma 
   -Tubular adenocarcinoma 
   -Mucinous adenocarcinoma 
   -Signet ring cell carcinoma 
  2. Adenosquamous carcinoma 
  3. Squamous cell carcinoma 
  4. Undifferentiated carcinoma 
  5. Unclassified carcinoma 
 
 
 
Other classifications commonly used: 
 Siewert classification; 
 Malignancies involving proximal gastric adenocarcinoma are 
divided into three types  
  
Type 1: Carcinoma in  Barrets  oesophagus or true esophageal  
  carcinoma extending to gastroesophageal junction. Total  
  esophagectomy with gastric pull through to the neck is needed. 
Type 2 : Tumor within 2cm of squamo columnar junction. Total  
  gastrectomy with necessary anastomosis is needed. 
Type3 :  Tumor in subcardial region. 
Borrmann”s  Classification: 
This is based upon morphological features of tumor 
 1.Single,polypoid carcinoma 
 2.Ulcerated carcinoma with clear cut margin 
 3.Ulcerated margin without clear cut margin 
 4.Diffuse carcinoma 
 5.Unclassified 
Japanese classification of gastric carcinoma: 
This classification is based on the following rules. 
 -The basic rules for clinical, surgical, pathological and final features. 
 -Specific rules for histology. 
  
 -Gastric biopsy specimen group classification 
 -Based on chemo radiotherapy response 
Nodal spread as per this classification: 
 N x-  nodes unknown/cannot be assessed 
 N o- no nodal spread 
 N 1 –Group 1 nodes involved 
 N 2  -Group 2 nodes involved 
 N 3 – Group 3 nodes involved 
Birmingham staging: 
 1. confined to mucosa/muscularis propria 
 2 . Muscularis/serosal involvement 
 3 –Nodal spread 
4a—Residual disease 
4b- Metastatic disease   
Types of spread in Gastric malignancy: 
 Gastric cancer spread occurs in multimodal fashion. The metastasis 
mainly  passes through lymphatics, via blood and along transperitonal 
route. 
  
Lymphatic route: 
This spread occurs by permeation and embolisation through 
lymphatics to subpyloric, gastric, pancreaticoduodenal, splenic, celiac, 
aortic and lastly to left supraclavicular nodes. Retrograde spread to 
mesenteric nodes in small and large bowel, signifies poor prognosis. 
Blood spread: 
This spread occurs to liver causing multiple liver secondaries which 
are presented as multiplr, hard nodules with umbilications due central 
necrosis. 
Transperitoneal route: 
This mode of spread can cause peritoneal seedlings leading onto 
ascites. Krukenberg tumor in ovary, is the presentation due to this type 
commonly seen in menstruating women. Rectal secondaries or Blumers 
shelf, Sister Mary Joseph type of umbilical secondaries occurs through this 
route.      
 
TNM STAGING 
T: Primary tumor 
Tis Carcinoma in situ; intraepithelial tumor without invasion of 
lamina propria 
  
T1 Tumor invades lamina propria or submucosa 
T2 Tumor invades muscularis propria or subserosa 
T3 Tumor penetrates serosa (visceral peritoneum) without invasion of 
adjacent structures 
T4 Tumor invades adjacent structures 
N:  Regional lymph node 
N0 No regional lymph node metastasis 
N1 Metastasis in 1 to 6 regional lymph nodes 
N2 Metastasis in 7 to 15 lymph nodes 
N3 Metastasis in more than 15 regional lymph nodes 
M:  Distant metastasis 
M0 No distant metastasis 
M1 Distant metastasis 
 
 
 
 
 
 
 
  
TNM Staging  
 
 
 
 
 
 
 
 
 
 
 
  
 
STAGE GROUPING 
STAGE T  N  M 
0  Tis  N0  M0 
IA  T1  N0  M0 
IB  T1  N1  M0 
T2  N0  M0 
II  T1  N2  M0 
T2  N1  M0 
T3  N0  M0 
IIIA  T2  N2  M0 
T3  N1  M0 
T4  N0  M0 
IIIB  T3  N2  M0 
IV  T4  N1–3  M0 
T1–3  N3  M0 
Any T Any N M1 
 
 
 
  
 
A case of carcinoma stomach presenting as  
Mass abdomen with Abdominal Distention 
 
 
 
 
 
 
 
 
 
  
 
The same case with Peritoneal and Omental Deposits 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Carcinoma stomach at Cardia and Fundus  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
A case of Linitis Plastica 
 
 
 
 
 
 
 
 
 
 
 
  
Liver secondaries in a case of carcinoma stomach 
 
 
 
 
 
 
 
 
 
 
 
  
PRESENTATION  OF  CARCINOMA  STOMACH; 
In  early  gastric  cancer patients are, mostly  asymptomatic. The  
non  specific  symptoms  are  indigestion, vague  epigastric  discomfort, 
constant  radiating  pain  which  is  not  related  to  food  intake.The  
specific  symptoms  depend  on  the  site  of  the  tumour. It  includes  
obstruction, dysphagia, and  mass in  metastatic  disease, liver  
secondraies, ascites, secondries  in  ovary, rectovesical  pouch, and  
umbilicus. The  unusual  presentations  are acanthosis  nigricans,Irish  
nodes  in  the  axilla. 
CLINICAL MANIFESTATIONS: 
        The  most  common  manifestations  are  recent  onset  of  loss  of  
weight and  appetite, early  satiety and  fatigue. The  most  common  sign  
is  anaemia. It  is of  microcytic  hypochromic  anaemia, and mostly  due  
to  iron deficiency  and  it occurs in forty      percentage of presentation.
The  other  features  are   upper  abdominal  pain, vomiting  with  features  
of  gastric  outlet  obstruction. In  advanced  cases  most  of  the  patients  
were  present  with  mass  abdomen. The  mass  in  pylorus  lies  above  
the  umbilicus, nodular, hard, with  impaired  resonance, mobile , and it 
moves  with  respiration, all  borders are  well made  out..When  it arises  
from  the  body  of  the  stomach, it  present as  only  mass  abdomen..The  
  
presence  of  epigastric  mass is a poor  prognostic  sign.10%  of  patients  
were    present  with  palpable  cervical  nodes, ascites, jaundice. Sister  
josephs  nodule  is  a  visible  and  palpable  secondary  deposit  at  the  
umbilicus. It  is  due  to  spread  along  the  lymphatics  around  the  
falciform  ligament. It  is  a poor  prognostic  sign. Trosiers  sign  is  an  
enlarged  lympnode  in  the  left  supraclavicular  fossa. It  indicates  
lymphatic spread  via  thoracic  duct. 
  
Diagnostic evaluation 
Distinguishing between peptic ulcer and gastric cancer on clinical 
grounds alone is usually impossible. Patients who were above the age of 
45 years  and having new-onset dyspepsia, as well as all patients with 
dyspepsia and alarm symptoms (weight loss, recurrent vomiting, 
dysphagia, evidence of bleeding, or anemia) or with a family history of 
gastric cancer should have prompt upper endoscopy and biopsy if a 
mucosal lesion is noted. Essentially, all patients in whom gastric cancer is 
part of the differential diagnosis should have endoscopy and biopsy.  
If suspicion for cancer is high and the biopsy is negative, the patient 
should be re-endoscoped and more aggressively biopsied. In some patients 
with gastric tumors, upper GI series can be helpful in planning treatment. 
  
Although a good double-contrast barium upper GI examination is sensitive 
for gastric tumors (up to 75% sensitive), in most centers, endoscopy has 
become the gold standard for the diagnosis of  Gastric malignancy. 
Preoperative staging of gastric cancer is best accomplished with 
abdominal/pelvic CT scanning with IV and oral contrast. MRI is probably 
comparable. The best way to stage the tumor locally is via EUS, which 
gives fairly accurate (80%) information about the depth of tumor 
penetration into the gastric wall, and can usually show enlarged (>5 mm) 
perigastric and celiac lymph nodes. In some centers, if the tumor is 
transmural (T3) or involves lymph nodes (enlarged nodes can usually be 
needled under ultrasound guidance), preoperative (neoadjuvant) 
chemotherapy is given. However, there are limitations to tumor staging 
with EUS. It largely is operator dependent and may underestimate lymph 
node involvement because normal-sized nodes (<5 mm) can harbour 
metastases.EUS is most accurate in distinguishing early gastric cancer 
(T1) from more advanced tumors. 
Positron Emission Tomography Scanning 
Whole-body PET scanning uses the principle that tumor cells 
preferentially accumulate positron-emitting 18 Ffluorodeoxyglucose. This 
modality is most useful in the evaluation of distant metastasis in gastric 
  
cancer but cannot so be useful in loco regional staging. PET scan is most 
useful when combined with spiral CT (PET-CT) and should be considered 
before major surgery in patients with particularly high-risk tumors or 
multiple medical co morbidities. 
Staging laparoscopy and peritoneal cytology 
To some extent, the usefulness of these modalities depends on the 
individual patient's situation as well as the treatment philosophy of the 
cancer team. The fundamental question is "will it make a difference to this 
patient's management?" Patients with gastric cancer who undergo R0 
resection (i.e., no gross residual disease) and are found to have positive 
peritoneal cytology (no gross carcinomatosis) have a much worse 
prognosis than thecytology negative group . It is controversial how much 
this information adds prognostically to that of pathologic staging (TNM). 
Whether this poor prognosis can be improved postresection with 
aggressive adjuvant treatment (systemic, or local intraperitoneal 
hyperthermic chemotherapy)is unknown. Unfortunately, it is also unclear 
how much these patients benefit from gastric resection. 
 Currently peritoneal cytology information is unlikely to change the 
treatment of patients with gastric cancer, and most patients without 
detectable distant metastases will have (and should have) gastric resection 
  
regardless of the peritoneal cytology results. A quick laparoscopic 
examination can occasionally reveal small peritoneal implants orliver 
metastases that were not detected on preoperative imaging studies and, in 
some patients (e.g., high risk for surgery or impressive carcinomatosis), 
this will change the operative plan and avoid a major but futile surgical 
procedure. Laparoscopy may be most useful in patients with proximal 
tumors or with adenopathy on spiral CT scan. An extensive laparoscopic 
staging procedure, although quite accurate, has not been widely adopted. 
Treatment 
Surgical removal of the tumor is the main stay as the treatment in  
most of the patients. With clinically resectable local and regional disease, 
gastric resection should be considered.. Obvious exceptions include 
patients will be patients who cannot bear the major abdominal resection, 
and presentation  in late stage along with extensive metastasis. The  aim of 
curative surgical treatment is resection of all tumor (i.e., R0 resection). 
Thus, all margins  should be free  and extensive and needed lymph node 
excision should done. 
Generally, the surgeon strives for a grossly negative margin of at 
least 5 cm. Some gastric tumors, particularly the diffuse variety, are quite 
infiltrative and tumor cells can extend well beyond the tumor mass; thus, 
  
gross margins beyond 5 cm may be desirable. Frozen section confirmation 
of negative margins is important when performing operation for cure, but 
it is less important in patients with nodal metastases beyond the N1 nodal 
basin.  
It should be strongly emphasized that many patients with positive 
lymph nodes are cured by adequate surgery. It should also be stressed that 
often lymph nodes that appear to be grossly involved with tumor turn out 
to be benign or reactive on pathologic examination. More than 15 resected 
lymph nodes are required for adequate staging. Therapeutic nihilism 
should be avoided and, in the low-risk patient, an aggressive attempt to 
resect all tumor should be made. The primary tumor may be resected 
enbloc with adjacent involved organs (e.g., distal pancreas, transverse 
colon, or spleen)during the course of curative gastrectomy. Palliative 
gastrectomy may be indicated in some patients with obviously incurable 
disease, but most patients presenting with stage IV gastric cancer can be 
managed without major operation. 
 
 
 
 
  
Extent of Gastrectomy 
The extent of gastric resection, is quite debatable issue. But radical 
subtotal gastrectomy still considered as gold standard. Unless required for 
R0 resection, total gastrectomy confers no additional survival benefit and 
may have adverse nutritional or quality-of-life consequences, and higher 
peri operative morbidity and mortality. Subtotal gastric resection typically 
involves .the following important procedures- ligation of vessels like 
gastric arteries,epiploic arteries at level of its orgin, Next is total removal 
tumor involved part which very often comes around major part of distal 
stomach, two cm of duodenum and removal of greater and lesser 
omentum, along with the exicision all involved lymph nodes. After this 
Billroth type 2 gastrojejunostomy is performed.  
Radical subtotal gastrectomy is generally deemed to be an adequate 
cancer operation in most Western countries, provided that the 
contingencies stated result in tumor-free margins, >15 lymph nodes, and 
the resection of all gross tumor. In the absence of involvement by direct 
extension, the spleen and pancreatic tail are not removed. 
 
 
  
Total gastrectomy with Roux-en-Y esophagojejunostomy may be 
required for R0 resection and maybe the best operation for patients with 
proximal gastric adenocarcinoma. The construction of a jejunal pouch 
maybe beneficial nutritionally, particularly for those patients with a good 
prognosis. Proximal subtotal gastric resection, a technically feasible 
alternative to total gastrectomy for some proximal gastric tumors, requires 
an esophago gastrostomy to a vagotomized distal gastric remnant. 
Pyloroplasty in this setting virtually guarantees bile esophagitis, and if the 
pylorus is left intact, gastric emptying may be problematic. An 
interposition of isoperistalic jejunum between the esophagus and antrum  
could be considered as an alternative reconstruction, but, all things 
considered, total gastrectomy usually results in superior functional, if not 
oncologic,results for most patients with proximal gastric cancer. 
 
 
 
 
 
 
 
  
Extent of Lymphadenectomy 
The Japanese Research Society for Gastric Cancer has numbered the 
lymph node stations that potentially drain the stomach. Generally these are 
grouped into level D1 (i.e., stations 3 to 6), level D2 (i.e., stations 1,2, 7, 8, 
and 11), and level D3 (i.e., stations 9, 10, and 12) nodes. Generally, D1 
nodes are perigastric, D2 nodesare along the hepatic and splenic arteries, 
and D3 nodes are the most distant. The operation described above (radical 
subtotal gastrectomy in the Extent of Gastrectomy section), which is by far 
the most commonly perform edprocedure in the United States for gastric 
cancer, is called a D1 resection because it removes the tumor and the 
perigastric D1 nodes. The standard operation for gastric cancer in Asia and 
specialized U.S. centers is the D2gastrectomy, which involves a more 
extensive lymphadenectomy (removal of the D1 and D2 nodes).  
 In addition to the tissue removed in a D1 resection, the standard D2 
gastrectomy removes the peritoneal layer over the anteriormesocolon and 
selectively over the pancreas, along with nodes along the hepatic and 
splenic arteries, and thecrural nodes. Splenectomy and distal 
pancreatectomy are not routinely performed, because this clearly has 
beenshown to increase the morbidity of the operation. Unfortunately, the 
randomized prospective trials that have been performed have not 
  
confirmed this survival advantage, but the morbidity and mortality in the 
D2 group was higher. This was mostly attributable to the splenectomy and 
distal pancreatectomy, which are no longer routinely done as part of the 
D2 gastrectomy. 
Palliative Treatment 
Patients with terminal illness needs better care,than cure to improve 
their quality of life. This will be the main aim of palliative treatment. The 
incidence of stage 4 disease varies, but often it falls between 20 to 30%.So 
all modalities of palliative treatment should be considered, before starting 
the care of the patients. It should be aimed to have minimal morbitity, so 
that patient can tolerate the treatment. this includes both medical and 
surgical therapy. Pain relief and symptomatic treatment is the main stay in 
medical management. 
Surgical interventions includes various bypass procedures, feeding 
jejunostomy. This can be done either by open type or through non 
operative type. Laser recannulization, endoscopic dilatation along with 
stent placement, are some examples of  this type. 
 
 
 
  
Adjuvant Therapy 
 Adjuvant therapy is mainly based on chemo and radiotherapy. There 
are umpteen number of drugs available, but still 5 flurouracil is considered 
as gold standard. There are lot of trials involving various combination of 
drugs. So it has be tailor made for the patints and more importantly it 
should be affordable  to the patients. Radiotherapy can be given alone ,or it 
can be combined along with chemotherapy.   
Early complications 
1. Any upper abdominal surgery will have effect on cardiovascular 
 system, respiratory system. 
2. Anastomotic leak 
3. Fluid collection or abscess formation. This occurs if lymph node 
 dissection was done. 
4. If drainage of gastric remanent  gets blocked,it lead on to vomiting 
5. Distruption of duodenal stump occurs, if afferent loop  is obstructed. 
 
 
 
  
Late complications: 
 Surgical resection of gastric malignancy will have major impact on 
the stomachs normal function.Both anatomical and physiological 
alterations affects the normal lifestyle of the patients.The commonly noted 
late complications are reflux gastritis,Dumping syndrome, and nutritional 
changes. 
 Reflux gastritis: 
  This is mainly due to alteration in the pyloric architecture. The 
biliary and pancreatic contents easily travels across the stomach, there by 
causing gastritis, since these contents are alkaline. 
 Medical treatment has little benefits .Some patients may require 
diversion of the small  bowel contents. 
  -Dumping syndromes: 
 The symptoms related to this syndrome are vomiting ,loose stools, 
abdominal pain and fullness .These clinical manifestations may due to 
hastened gastric emptying. Late dumping symptoms may de due to 
increase in insulin after food 
 
  
  -Nutritional   deficiencies: 
 Among this iron and vitamin B12 deficiencies are common, because 
intrinsicfactor  which is important for absorption of vitamin B12 will be 
absent after gastric resection.  
Immunotheraphy  as an  adjuvant: 
       It  is  given  in  stage  3  carcinoma  after  total  gastrectomy. It is  
starts  from  5
th
  postoperative  day  to  the  end  of 2  years. It  is  based  on  
preoperative  cell  counts. Which  can  be  improved/modulated  by  this  
therapy. Residual  cancer  cells   or  micrometastases  can  be  eradicated  
by  this  therapy. Regime  contains; initially  immunotherapy  using  
weekly  intra  muscular  injections of    picibanil (streptococcus  pyogenes  
derived) immune  agent  1  clinical  unit  is  given  on  5
th
 postoperative  
day. from  10
th
 postoperative  day  onwards, chemotherapy  regime  
consisting  of  mitomycin C  and  5 Fu. Mitomycin C   4mg/50 kg  IV  
Twice  weekly  for  two  weeks, then  weekly  for  six  weeks. 5  FU  as  
500mg/50jg  IV  twice  weekly  for  two  weeks, then  weekly  for  six  
weeks, then  600mg/50  kg  orally  daily b for  two  years. Neoadjuvent 
therapy: This can be given to downstage the tumor and surgery can be 
done later. The main combination of drugs will be ECF-epirubicin, 
cisplatin, 5-flurouracil. Then EAP (epirubicin, adriamycin, cisplatin) and 
  
FDT (flurouracil, doxorubicin, triazinate) are also used. Newer drugs like 
Bevacizumab are under trial.  
Recent advances in treatment: Although early detection of gastric 
cancer is possible, it requires cumbersome procedures like upper 
gastrointestinal scopy. But in Japan screening for high risk population 
revealed excellent results. So patients in our country most of the time 
patient are presented with advanced disease. The recent advancement in 
screening of malignancies related to stomach will be 
1. Serial analysis on gene expression 
2. Photoflurography 
 3. serum pepsinogen estimation. 
 
 
 
 
 
 
 
 
 
  
  Role of Biological treatment in Gastric Carcinoma: 
  Monoclononal antibodies  are the newer arrival in the treatment for 
any cancer patients.Their targets will be the genes responsible for 
carcinogenetic changes.Number of drugs has passed the trial and are in 
use.Japanese are the pioneers in this type of studies.The commonly used 
drugs for gastric carcinoma will be Trastuzumab and Bevacizumab.Both 
these drugs can be given along with chemotherapy for the betterment of 
patients quality of life after major gastric surgery.Trastuzumab specifically 
attack the HER-2 protein,there by cuts the genetic  abnormal 
expression.Acute infusion reaction,left heart failure and the cost of the 
drug arethe major limitations for its routine use.Bevacizumab is  an 
immunogloblulin G1It specifically binds vascular endothelial growth 
factor to attain its action.   
                                    
 
 
 
 
 
 
  
 
METHODOLOGY 
This is prospective study for EVALUATION  OF CASES WITH 
CARCINOMA  STOMACH in  Tirunelveli Medical  College  Hospital, 
Tirunelveli   during the  period of    18 months, from Feb 2011 to July 
2012.. Formal  ethical  committee   approval  was  obtained. Patients  were 
informed  about  the  study  and  consent  was  obtained. 
SOURCE  OF  DATA: 
                      Patients  admitted  in  the  Department  of  General  Surgery, 
Tirunelveli  Medical  College  who  were  diagnosed  as  carcinoma  
stomach. 
Design of study: 
Prospective study 
Period of study: 
18 months 
Sample size: 
103 cases of carcinoma stomach 
Stastical method: 
Our data is represented in tabulation, graphs  
 
  
 
Method of Collection of Data 
The present  study was, made out from 103 patients of carcinoma 
stomach admitted in Tirunelveli medical college and hospital during 
period of Feb 2011 – July2012.After obtaining an informed written 
consent, clinical  history, detailed examination and relevant investigations 
were done. After confirming the diagnosis, evaluating the nature of the 
disease and considering the patient general conditions ,treatment planned 
including both surgical and non surgical measures . If needed secondary 
analysis of medical records of these patient will be referred if required. 
The pathology report of the patient are been followed up with an earnest  
attempt  to  study  all  the  cases  in  detail and to profile my observation 
made out of them. 
Inclusion  criteria: 
1. Male  and  females   with  complaints  and  investigations  
suggestive  of  carcinoma stomach. 
2. Both  operable  and  inoperable  cases. 
3. Advanced  cases  
Collobrating Department:  Pathology 
 
  
 
RESULTS 
Sex Distribution 
 Gastric cancer is more common in males. 59% of the cases being 
males in the study. Male female ratio was 3:2  
 
Sex Total Percentage % 
Male 61 59 
Female 42 41 
                                             
 
 
 
 
 
 
 
 
 
 
  
 
Age Distribution 
 Carcinoma stomach was more common in the age group of 45 -54 
yrs. Increase in incidence was found above the age of 44 years. The 
youngest patient was aged 25 yrs and oldest was 76 yrs old. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age 
Male Female 
Total % Total % 
< 25 0 0.0 0 0.0 
25 – 34 0 0.0 1 2.4 
35 – 44 5 8.2 5 11.9 
45 – 54 12 19.7 21 50.0 
55 – 64 23 37.7 7 16.7 
65 – 74 16 26.2 7 16.7 
75 + 5 8.2 1 2.4 
Total 61 100.0 42 100.0 
  
Age Distribution  
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Blood Group Distribution 
  Blood group A positive showed the highest association both in  
males and female. A percentage of 36% in males and 40% in females. 
Next common blood groups accounted for the occurrence of gastric 
carcinoma in this study was O positive, B positive. In this study all the Rh 
negative groups found to be on the lower side, which was shown on below 
table. 
Blood 
Group 
Male Female 
Total % Total  % 
A+ve 22 36.1 17 40.5 
B+ve 12 19.7 10 23.8 
AB+ve 8 13.1 8 19.0 
O+ve 15 24.6 7 16.7 
O-ve 2 3.3 0 0.0 
AB-ve 1 1.6 0 0.0 
A-ve 1 1.6 0 0.0 
Total 61 100.0 42 100.0 
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Socioeconomic Status 
 In the present study all the cases belonged to the low socioeconomic 
status. The prevalence among high socioeconomic group could not be 
studied as none of the patients belonged to this strata. 
Socio Economic 
Status 
Total Male Female 
Cases % Cases % Cases % 
Low 103 100 61 59 42 41 
Medium 0 0 0 0 0 0 
High 0 0 0 0 0 0 
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Comparison of Site Distribution 
 In this study the common site of carcinoma stomach was found to be 
pyloric antrum for both males and females. The total number of males 
included in this study was 61.Out of this, 55 patients were diagnosed to 
have pyloric growth. This accounts for 90.2%.Considering the female 
patients, out of 42 patients, 32 patients were diagnosed as pyloric growth. 
This accounted for 76.2%.   
Sub site 
Total cases Male Female 
Total % Total % Total % 
OG junction 5 4.9 1 1.6 4 9.5 
Cardiac & Fundus 4 3.9 1 1.6 3 7.1 
Body 6 5.8 3 4.9 3 7.1 
Antrum & Pylorus 87 84.5 55 90.2 32 76.2 
Linitis Plastica 
(Diffuse) 
1 1.0 1 1.6 0 0.0 
Total 103 100.0 61 100.0 42 100.0 
 
 
                                              
 Comparison of Site Distribution
 
 
Comparison of Environmental Factors
  In this study the following environmental  factors were 
analysed, dietary habits,
into account. In dietary habits mixed diet is the main culprit for occurrence  
of gastric carcinoma. 
genders..In dietary habits spicy food is the major factor which accounts to 
the occurrence of gastric carcinoma.
of alcohol . In this study 15.2% of male patients had the addiction to 
alcohol which was the major factor regarding occurrence of gastric 
carcinoma. Smoking is also the major risk fac
84%
 
 
 
 smoking, alcohol, tobacco chewing were taken 
This contributes to 39.9% with relation both 
 Next major factor is the consumption 
tor accounting to gastric 
5%
4%
6%
1%
Total cases Total
OG junction
Cardiac & Fundus
Body
Aotrum & Pylorus
Linitis Plastica (Diffuse)
 
  
carcinoma. In this study it has 14.2% of male patients who were taken into 
count. Tobacco chewing is taken into account in both genders. Contrary to 
smoking ,in my study female population exceeds male population with 
regarding to occurrence of stomach carcinoma. Female population 
accounted for 7.5%,whereas male patients only 3.7% were noted in this 
study.   
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Table showing Comparison of Environmental Factors 
Risk Factors 
Total cases Male Female 
Total % Total % Total % 
Mixed Diet 99 30.7 59 25.7 40 43.0 
Veg. Diet 4 1.2 2 0.9 2 2.2 
Smoked food 10 3.1 8 3.5 2 2.2 
Spicy 103 31.9 61 26.5 42 45.2 
Smoking 46 14.2 46 20.0 0 0.0 
Alcohol 49 15.2 49 21.3 0 0.0 
Tobacco 
chewing 
12 3.7 5 2.2 7 7.5 
Total 323 100.0 230 100 93 100 
 
 
 
 
 
 
 
 
  
Symptom Analysis in the patients of carcinoma stomach 
 In this study abdominal pain is the most common symptom reported 
in both genders.This is closely followed by nausea and vomiting, loss of 
appetite and dyspepsia..Next peculiar symptom is the ball rolling 
movement, which accounts for 5.1% in both sexes. Dysphagia, malena, 
hemetemesis and drug intake also contributes to the occurrence of gastric 
carcinoma.   
Symptoms 
Total Cases Male Female 
Total % Total % Total % 
Abdominal pain 92 23.5 52 22.0 40 25.6 
Nausea/vomiting 87 22.2 51 21.6 36 23.1 
loss of weight & 
appetite  
23.0 54 22.9 36 
23.1 
Dyspepsia 70 17.9 46 19.5 24 15.4 
Jaundice 1 0.3 1 0.4 0 0.0 
Dysphagia 14 3.6 8 3.4 6 3.8 
Malena 7 1.8 3 1.3 4 2.6 
Hemetemesis 3 0.8 2 0.8 1 0.6 
Ball rolling 
movement 
20 5.1 12 5.1 8 5.1 
Drugs intake 8 2.0 7 3.0 1 0.6 
Total 392 100.0 236 100.0 156 100.0 
 
  
 
Analysis of signs in carcinoma stomach 
  Among all the cases of carcinoma stomach anaemia was found 
to be the most common sign, 42.2% in males and 41.7% of females. This 
was followed byMass abdomen which was reported in 21% of all cases 
Visible gastric peristalsis is the next common sign, which comes around 
12% in both sexes. Ascitis was reported with equal percentage in both 
sexes. Only one case was reported with presentation of supraclavicular 
node, that too male patient. 
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Signs 
Total cases Male Female 
Total % Total % Total % 
Anemia 68 42.0 38 42.2 30 
41.7 
Icterus 3 1.9 3 3.3 0 
0.0 
Supraclavicular 
node 
1 0.6 1 1.1 0 0.0 
Dehydration 6 3.7 3 3.3 3 
4.2 
Pedal edema 5 3.1 5 5.6 0 
0.0 
Ascitis 11 6.8 6 6.7 5 
6.9 
VGP 20 12.3 12 13.3 8 
11.1 
Mass abdomen 34 21.0 18 20.0 16 22.2 
Hepatomegaly 11 6.8 3 3.3 8 11.1 
Succession 
splash 
3 1.9 1 1.1 2 2.8 
Total 162 100.0 90 100.0 72 
100.0 
 
0
10
20
30
40
50
60
70
80
Signs
Total cases Total
Male Total
Female Total
  
Comparison of Symptoms and site of Tumour 
  Abdominal pain, nausea, vomiting, loss of weight, dyspepsia 
and hematemesis were the most common symptoms in patients with lesion 
in antrum and pylorus. 
  In patients with OG junction growth, dysphagia was the most 
common symptom. In cardiac and fundus tumours the common symptoms 
were nausea, vomiting, loss of weight and dyspepsia. There was one 
patient with Linitis plastica  with symptoms of abdominal pain, nausea, 
vomiting, hematemesis,  jaundice and melena. 
Symptoms Total 
OG 
Junction 
Cardial & 
Fundus 
Body 
Antrum & 
Pylorus 
Linitis 
plastic 
Total % Total % Total % Total % Total % 
Abdominal 
pain 
92 5   3   6   77   1   
Nausea / 
Vomiting 
88 5   4   6   72   1   
loss of weight 
& appetite 
90 5   4   6   75   0   
Dysphagia 14 1   1   2   10   0   
Dyspepsia  70 3   4   5   57   1   
Hematemesis 3 0   0   0   2   1   
Malena 7 0   0   1   5   1   
Jaundice 1 0   0   0   0   1   
Ball rolling 
movement 
20 3   1   3   13   0   
Total 
 
22 0 17 0 28 0 304 0 6 0 
  
Comparison of Symptoms and site of Tumour 
 
 
Analysis of site of tumor with signs 
   Anaemia was the most common sign in cases with tumour in 
any part of the stomach. Followed by mass abdomen, visible gastric 
peristalsis and ascitis which were most common in cases with tumor in 
antrum and pylorus. Supraclavicular node was present in one case of tumor 
in antrum.  
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Total % Total
Anemia 5 3.0 
Icterus 0 0.0 
Supraclavicul
ar node 
0 0.0 
Dehydration 0 0.0 
Pedal edema 0 0.0 
Ascitis 0 0.0 
VGP 1 0.6 
Mass 
abdomen 
0 0.0 
Hepatomegaly 0 0.0 
Succussion 
splash 
0 0.0 
Total 6 3.6 7
 
 
Representation of Signs with Relation Side 
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Fundus 
Body 
Antrum & 
Pylorus 
 % Total % Total %
3 1.8 6 3.6 53 32.1
0 0.0 0 0.0 3 1.8
0 0.0 0 0.0 1 0.6
0 0.0 0 0.0 9 5.5
0 0.0 1 0.6 4 2.4
0 0.0 0 0.0 11 6.7
1 0.6 2 1.2 16 9.7
2 1.2 3 1.8 29 17.6
1 0.6 1 0.6 9 5.5
0 0.0 0 0.0 3 1.8
 4.2 13 7.9 138 83.6
 
Total Total Total
Body Antrum 
& Pylorus
Linitis 
plastica
Anemia
Icterus
Supraclavicular node
Dehydration
Pedal edema
Ascitis
Vgp
Mass abdomen
Hepatomega
Succussion splash
Linitis 
plastica Total 
 Total % 
 1 0.6 68 
 0 0.0 3 
 0 0.0 1 
 0 0.0 9 
 0 0.0 5 
 0 0.0 11 
 0 0.0 20 
 0 0.0 34 
 0 0.0 11 
 0 0.0 3 
 1 0.6 
 
 
 
  
Comparison of Histology 
  Histopathological analysis was done for all resected tumors. In 
this study the most common type was found to be moderately 
differenciated tumour. This accounts to 41% in males and 47.6% in 
females. Next common type reported was well differentiated type, which 
accounted to 44.3% in males, and 26.2% in females. Female patients has 
maximum number of poorly differentiated type. The least common types 
reported was undiffrentiated, mucinous and signet ring types .  
Histology 
Study Male Female 
Total 
Cases 
% Cases % Cases % 
Well 38 36.9 27 44.3 11 26.2 
Moderate 45 43.7 25 41.0 20 47.6 
Poorly 15 14.6 5 8.2 10 23.8 
Undifferentiated 0 0.0 0 0.0 0 0.0 
Mucinous 4 3.9 3 4.9 1 2.4 
Signet ring 1 1.0 1 1.6 0 0.0 
Total 103 100.0 61 100.0 42 100.0 
 
 
 
                                                
 
 Histological Representation 
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Comparison of histology & the site of the tumour 
 Most of the OG junction tumors were found to be well 
differentiated. Tumors in  Cardia, fundus, body, antrum and pylorus were 
mostly moderately differentiated tumors.  
The case with linitis plastic was found to be mucinous tumor in 
histopathology. One case of signet ring tumor was seen in a case of tumor 
at the pylorus and antrum. 
   
 
 
                 
Histology 
OG 
Junction 
Cardial 
& 
Fundus 
Body 
Antrum & 
Pylorus 
Linitis 
plastica 
Total % 
Well 3 1 3 31 0 38 36.9 
Moderate 1 2 2 40 0 45 43.7 
Poorly 1 1 0 13 0 15 14.6 
Undifferentiated 0 0 0 0 0 0 0.0 
Mucinous 0 0 1 2 1 4 3.9 
Signet ring 0 0 0 1 0 1 1.0 
Total 5 4 6 87 1 103 100.0 
  
Comparison of age group & site of tumour 
Tumors in the OG junction were most common in the age group of above 
45 years of age. Tumors in the cardia and fundus were common in age 
group of 45-54 years and 65-74 years. Tumors in the body of stomach 
were common in cases above the age of 55 years. Tumors in the antrum 
and pylorus were found most commonly in the age group of 45-54 years. 
    
   
 
 
 
 
 
 
 
Age 
Group 
OG 
Junction 
Cardia & 
Fundus 
Body 
Antrum & 
Pylorus 
Linitis 
plastica 
Total % Total % Total % Total % Total % 
< 25 0 0.0 0 0.0 0 0.0 0 0.0 0 0.0 
25 – 34 1 20 0 0.0 0 0.0 0 0.0 0 0.0 
35 – 44 0 0.0 0 0.0 0 0.0 10 11.5 0 0.0 
45 – 54 1 20 2 50 1 16.7 27 31.0 0 0.0 
55 – 64 1 20 0 0.0 2 33.3 25 28.7 1 100 
65 – 74 1 20 2 50 2 33.3 20 23 0 0.0 
> 75 1 20 0 0.0 1 16.7 5 5.7 0 0.0 
Total 5 100 4 100 6 100 87 100 1 100 
  
Age group and site of Tumor 
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                                         DISSCUSSION 
Gastric carcinoma remains to be one of the important malignant 
diseases, with significant geographical, ethnic and socioeconomic 
differences in distribution. Once it was considered as the second most 
common malignancy in the world, now it is on decreasing trend. This may 
be due to well proven facts like recognition of H.pylori, improved dietary 
habits, low intake of preserved foods, salt etc. In western countries upper 
gastric carcinoma predominates, whereas in India antral growth was found 
to be the most common presentation. 
Although worldwide the incidence is on decreasing trend, in India 
Gastric carcinoma, still a major malignant disease which has an impact 
over low socioeconomic population. So with relevance to these facts this 
study was undertaken to analyse the various factors influencing the 
incidence of Gastric carcinoma and various treatment modalities available 
in Department of General Surgery, Tirunelveli Medical College Hospital.    
 
                                                 
 
 
 
  
(i) Sex distribution: 
(ii) Gastric carcinoma is more common in males with global age 
standardised incidence for males about 2.2 times higher than females. 
In my study group 59% of cases were males and 41% were females, 
compared to result of sumathi et al 2009. 
(iii) Age distribution: Age wise trends in carcinoma stomach have been 
reported worldwide being largely a disease of older age group in most 
countries. In this study maximum number of cases were seen above 
age of 45 years. This finding correlates with the study done Urmi Sen 
et al in eastern India, which also reported a similar age trend with 
increasing incidence of Gastric carcinoma with age.  
In this study the youngest was aged 25 and oldest was 76 years of age. 
(iv) Socioeconomic status: As the study was conducted in a government 
hospital, most of the cases belonged to low socioeconomic status. The 
scenario is similar across india where majority of population belonging 
to the lower socioeconomic status. The results were comparable to 
results of gajalakshmi et al1995. 
(v) Blood group: The association of blood group A is well known and the 
same results were obtained in this study. Other blood groups B positive 
and O positive was noted to be on lower side on occurrence of gastric 
  
carcinoma. In this study Rh negative group patients were found to be 
on least occurrence. The results were comparable with studies by 
kamalesh guleria et al, Punjab and jose et al,kerala. 
(vi) Environmental factors: Gastric cancer is known to be associated with 
several environmental factors among which diet has an important role. 
The association of diet has been studied extensively by various 
authors. The results of this study were similar to those obtained by 
sumathi et al, in which spicy diet and mixed food were found to be 
major environmental risk factors Alcohol consumption and smoking 
among the male patients was the next major factor which contributes to 
the increasing incidence of Gastric carcinoma. Tobacco chewing also 
found to be one the environmental factors which has an impact on the 
rising trend of Gastric carcinoma, especially among female patients. 
All these findings in this study were well comparable with study done 
by Sumathi et al.  
(vii) Symptoms : Abdominal pain was the most common symptom reported 
in ninety two  of the cases compared to 56.6% in the study done by 
Safee et al. Next common symptoms noted were nausea and vomiting, 
loss of appetite/weight and dyspepsia. These findings also well 
  
correlates along with the study done by Safee et al. Dysphagia, malena, 
hemetemesis are the symptoms with least occurrence in this study.  
(viii) Signs : In this study anemia was the most common sign noted in both 
sexes. Although anemia is the common finding among the population 
here,this finding correlates similar to study done by Kaiser Jamil et 
al.Next common signs were mass abdomen and visible gastric 
peristalsis.Ascites was also noted in few cases. 
(ix) Site specific presentation: In this study, Pylorus and antrum  were the 
most common site of occurrence of gastric cancer. This accounts to 
81% of total cases, and this findings are well comparable with study 
done by Cherian et al. 
(x)  Histology : In this study most of the cases were moderately 
differentiated as compared to safe et al which constituted poorly 
differentiated tumors 
                                 
               
 
 
 
 
  
                                                 SUMMARY 
 Gastric carcinoma is the disease of old age as the incidence increases 
with advancing age. The incidence has declined in the world because of 
changing diet, food preparation and environmental factors. This study was 
done to study the incidence of gastric carcinoma in Tirunalveli medical 
college hospital Tirunelveli. 
 The incidence of gastric carcinoma is more among males(3:2). The 
age of incidence ranges from 25 – 75 years, most commonly over 45 years. 
The youngest being at the age of 25 years. Increased incidence of 
carcinoma stomach was found in patients of both sex taking spicy food. 
Smoking and Alchohol also contributes the occurrence of Gastric 
carcinoma. 
 The patients with A positive blood group were found to be more 
susceptible to gastric carcinoma. The common symptoms presented in this 
study were abdominal pain, nausea and vomiting, loss of appetite/weight. 
Anemia, mass abdomen and visible gastric peristalsis were the common 
signs. This shows the patients with advanced stage are turning up to the 
hospital.    
 The most common site observed were the pylorus and antrum. The 
male patients commonly showed well differentiated tumors, whereas the 
  
females had higher incidence of moderately differentiated tumors. Most of 
the well differentiated tumors were found in the oesophagealgastric 
junction, whereas pyloric antal tumors showed moderate differentiation. 
 As most of the patients in the study presented in advanced stages 
treatment was palliative in the form of gastro jejunostomy and 
jejunojejunostomy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                       CONCLUSION 
 Gastric cancer mortality rate have remained relatively unchanged 
over the years in India, inspite of various investigative and treatment 
modalities. This    may be due late detection of disease, which is the 
important factor in relation to the prognosis and outcome of the disease. 
Although there are lot of screening investigations for early detection of 
gastric carcinoma, in India due to cost benefit ratio it becomes impossible 
.This was well noted in this study as the most of the patients were 
presented with advanced symptoms and signs. So the palliative treatment 
was the major treatment modality observed in this study. So in future 
,early detection of of Gastric carcinoma should be our main objective, so 
that we can reduce the mortality rate, and importantly to improve the 
quality of life in patients suffering from Gastric carcinoma 
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PROFORMA 
Name: 
Age: 
Sex: 
IP no: 
Occupation: 
Socioeconomic status: 
Address: 
Date of Admission: 
Date of surgery : 
Date of Discharge: 
Complaints: 
Mass Abdomen: 
 Duration; 
 Size: 
 Site; 
Pain abdomen: 
 Site ; 
Nature: 
Duration: 
Radiating nature: 
Aggravating factors: 
Relieving Factors: 
Vomitting: 
 Nature: 
Spontaneous/ Induced; 
 Colour: 
Content: 
Foul smelling: 
Blood Stained: 
Dysphagia: 
 Duration: 
 Solids/ Liquids / Both 
Dyspepsia: 
H/o Ball rolling movements 
H/o Loss of weight/Loss of apetite 
H/o Weakness 
H/o Abdominal distension 
H/o Jaundice 
H/o Hemetemesis / Melena 
  
H/o Fever 
H/o Pruritus 
H/o Drug intake 
Past History: 
 DM /HT / TB / Bronchial Asthma / IHD 
H/o gastritis & treatment 
H/o previous surgery 
H/o Blood transfusion 
Family History: 
Personal History: 
Dietary Habits : Veg / Non veg 
 High consumption of animal fat 
 High salted & pickled food 
 Smoked food 
H/o smoking – No.of cigarrettes / day & duration 
H/o alchohol intake-Quantity & duration 
H/o  Tobacco chewing 
Bowel & Bladder habits 
Menstrual History : 
General Examination: 
 Nutrition 
Hydration status 
Anemia  
Jaundice 
Pedal edema 
Lymph nodes 
Per Abdomen Examination: 
Inspection-Site of mass 
 Size  
 Shape 
 Movement with respiration 
 Umbilicus 
 VGP 
 VIP 
 Venous pulsation 
 Ascites 
 Scar 
Palpation – Consistency 
  
 Warmth 
Tenderness 
 Confirmation of Inspection Findings 
 Guarding & Rigidity 
 Organomegaly 
Percussion : 
 Liver Dullness 
 Over the mass 
 Shifting Dullness 
 Fluid thrill 
 Free Fluid 
Auscultation:  Bowel sounds 
   Succession splash 
Bruit 
Digital rectal examination: 
Other  systems : 
 CVS,   RS ,   CNS,  LOCOMOTOR 
CLINICAL DIAGNOSIS: 
Investigations: 
 Urine Albumin, sugar, deposits 
 Complete Hemogram 
 Blood Gr & Typing 
 Blood Sugar, urea, creatinine, electrolytes 
 LFT 
 CXR 
 X-ray Abdomen 
 ECG 
 FNAC 
 UGI Endoscopy &  Biopsy 
 USG Abdomen & Pelvis 
 CT Abdomen 
 HPE  
 Barium meal in selective cases 
 Pre operative treatment Given – RT, CT  
  
 
 
 
Operative Notes:  
 
 
 
 
  
Post Operative Follow up. 
  Day of Ryle’s tube removal 
  Day of suture removal 
  Complications 
  Chemotherapy   
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1 
Gobala krishnan 
      
H 40525 58M L 
   
+ 
      
+ M A 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ AW thickening 
2 
Leelavathi 
      
H 
13322 50F L 
       
- 
      
- V CF 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- B+ Growth B and F 
3 
Muthiah 
      
H 3663 70M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
+ 
       
- O+ Growth body 
4 
Jeyaraj 
      
H 
2845 60M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ AW thickening 
5 
Santhanam 
      
H 47408 60F L 
       
- 
      
- M OG 
       
+ 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
   
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
- A+ Growth OGJ 
6 
Francis 
      
C 
29859 55M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
+ 
       
+ 
   
+ 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
        
- 
       
- AB+ Dilated stomach 
7 
Poolachi 
      
H 21595 40F L 
       
- 
      
- V A 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ 
AW thickening; PP 
nodes + 
8 
Pandi 
      
H 33651 57M L 
       
+ 
      
+ M A 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
   
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- A+ AW thickening 
9 
Kalimuthu 
      
H 
55467 58M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ AW thickening 
10 
Ponaiya 
      
H 61855 60M L 
       
+ 
      
+ M PA 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ PA growth 
11 
Susila 
      
H 12822 50F L 
       
- 
      
- M OG 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- A+ OGJ growth 
12 
Muthiah 
      
H 37677 57M L 
       
+ 
      
- V P 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
     
- 
       
- 
       
- 
        
- 
       
- AB+ Pylorus growth 
  
13 
Kumar 
      
H 15487 47M L 
       
+ 
      
+ M P 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ 
Ulcerative growth 
pylorus 
14 
Chellapandi 
      
H 
3668 40M L 
       
+ 
      
+ M P 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ 
Ulcerative pylorus 
growth 
15 
Periakannan 
      
H 61852 60M L 
       
+ 
      
+ M P 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
    
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- AB+ PA growth 
16 
Subbaiah 
      
H 
59597 65M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ 
AW thickening with 
GOO 
17 
Ponnusamy 
      
H 53848 55M L 
       
+ 
      
+ M P 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ 
Ulcerative growth 
pylorus 
18 
Murugesan 
      
H 
56309 49M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ 
Distended stomach with 
GOO 
19 
Sundar 
      
H 39244 48M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
     
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ Growth antrum GOO 
20 
Nagaraj 
      
H 13810 45M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
+ 
        
+ 
       
- A+ 
Distended stomach with 
GOO 
21 
Gopal kambar 
      
H 40525 58M L 
       
- 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Growth antrum GOO 
22 
Paulraj 
      
C 10143 72M L 
       
+ 
      
+ M A 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ 
PA growth extending to 
proximal part 
23 
Amirthapuspham 
      
H 31318 58F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
+ A+ 
AW thickening with 
GOO 
24 
Chandra 
      
H 11224 40F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ Antral growth 
25 
Ramalakshmi 
      
H 48512 53F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Growth antrum GOO 
26 
Fathima 
      
M 29246 54F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
+ 
       
+ B+ Antral growth;PPNLA 
27 
Pappa 
      
H 47314 46F L 
       
- 
      
- M B 
   
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
+ B+ UP growth body 
28 
Valli 
      
H 
34517 65F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- A+ 
AW thickening with 
GOO 
  
29 
Shanmugavadivu 
      
H  31722 65F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
    
- 
        
- 
       
- B+ 
AW thickening with 
GOO 
30 
Gracie 
      
C 
38296 70F L 
       
- 
      
- M A 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- AB+ 
AW thickening with 
GOO 
31 
Thangamani 
      
H 
56449 70F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ Growth pylorus 
32 
Chelliah 
      
H 40952 65M L 
       
- 
      
+ M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
+ 
       
- B+ 
Gastric wall 
thickening;PF;LS;ascitis 
33 
Elias 
      
C 42512 55M L 
       
- 
      
+ M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
     
- 
       
- 
        
- 
       
- O+ Growth antrum  
34 
Subramaniyan 
      
H 48622 59M L 
       
+ 
      
+ M A 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
   
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
- A+ Growth antrum  
35 
Chellappa 
      
H 27574 58M L 
       
- 
      
+ M A 
       
+ 
       
+ 
   
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- B+ Growth antrum  
36 
Ramasamy 
      
H 30969 62M L 
       
- 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB- 
AW thickening;minimal 
ascitis 
37 
Mariappanadar 
      
H 6963 80M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- B+ AW thickening 
38 
Kanagarani 
      
H 5081 45F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- AB+ AW thickening 
39 
Chendu 
      
H 40905 45F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- AB+ AW thickening 
40 
Ramalakshmi 
  H 
7805 49F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ NS 
41 
Kamalam 
      
H 15031 49F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
+ A+ AW thickening 
42 
Esakkiammal 
      
H 58250 44F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
    
- 
       
- 
       
- 
       
+ 
        
- 
       
- AB+ Growth antrum;ascitis 
43 
Saraswathy 
      
H 47135 47F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ AW thickening 
44 
Arunachalam 
      
H 32247 65M L 
       
- 
      
+ M OG 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
- A+ Growth PA 
45 
Ramasamy 
      
H 57322 47M L 
       
+ 
      
+ M B 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
+ B+ Growth body;LS 
  
46 
Muthiah 
      
H 36663 70M L 
       
+ 
      
+ M B 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
        
- 
       
- AB+ Growth body 
47 
Chellaiah 
      
H 49419 70M L 
       
+ 
      
+ M B 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ ? CA stomach 
48 
Mariappan 
      
H 52278 45M L 
       
+ 
      
+ M A 
      
+ 
       
- 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ AW thickening;PPNLA 
49 
Ramasamy 
      
H 48509 65M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
     
- A+ 
Diffuse circumferential 
AW thickening 
50 
Arunachalavadivu 
      
H 
8346 66F L 
       
- 
      
- M CF 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- A+ UP growth B and F 
51 
Shanmugavel 
      
H 19947 62M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ ? CA stomach 
52 
Moorthy 
      
H 35235 48M L 
       
+ 
      
+ M A 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
   
- 
       
- B+ Antral growth 
53 
Ulaganathan 
      
H 
5341 65M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- B+ 
Gastric wall thickening 
at pyloric antrum 
54 
Arumugathai 
      
H 3104 25F L 
       
- 
      
- M OG 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
+ A+ 
Hepatomegaly with 
PPNLA 
55 
Mailerumperumal 
      
H 
59459 59M L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ 
Gastric wall thickening 
at pyloric antrum 
56 
Pandian 
      
H 58068 65M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
      
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
        
- 
       
- B+ AW thickening 
57 
Sundaram 
      
H 57450 65M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ AW thickening 
58 
Rathinasamy 
      
H 
26665 35M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ 
Dilated stomach with 
GOO 
59 
Krishnan 
      
H 9304 80M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
   
- 
       
- 
       
- 
        
- 
       
+ A+ 
Hypoechoeic mass 
epigastric region 
60 
Subramaniyan 
      
H 43728 58M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Pyloric growth 
61 
Sokkalingam 
      
H 
27941 65M L 
      
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- A+ Dilated stomach 
  
62 
Philip 
      
C 23954 60M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ AW thickening 
63 
Guruvaiah 
      
H 49002 60M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
    
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ 
Distended stomach with 
GOO 
64 
Subramaniyan 
      
H 
18582 72M 
––
–L 
       
+ 
      
+ M A 
   
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ AW thickening 
65 
Vimalalincythilagam 
      
C 
33249 61F L 
       
- 
      
- M B 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ UP growth body 
66 
Kallapiran 
      
H 22920 42M L 
       
+ 
      
- M A 
     
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ AW thickening 
67 
Vasudevan 
   
H 25385 49M L 
       
+ 
      
- M A 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ AW thickening 
68 
Rama lakshmi 
      
H 54213 53F L 
       
- 
      
- M B 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
+ B+ 
Ulcerative growth 
antrum 
69 
Samuvelraj 
      
C 
57493 70M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ 
AW 
thickening;distented 
stomach 
70 
Madathy 
      
H 
32353 45F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
   
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- B+ AW thickening 
71 
Kajamydeen 
      
M 32246 65M L 
       
+ 
      
+ M A 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ PA growth 
72 
Shanmugathai 
      
H 
45663 54F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
     
- 
       
- 
        
- 
       
- A+ Pyloric wall thickening 
73 
Kallimuthu 
      
H 53676 48M L 
       
+ 
      
- V A 
       
- 
       
+ 
       
- 
       
- 
   
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
+ 
       
- 
        
- 
       
- A+ Pyloric wall thickening 
74 
Palani 
      
H 2033 48M L 
       
+ 
      
+ M A 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ 
Dilated stomach with 
LS 
75 
Velsamy 
      
H 42487 77M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- A+ AW thickening with LS 
76 
Velayutham 
      
H 55884 51M L 
       
+ 
      
+ M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ AW thickening;PPNLA 
77 
Karupaiyee 
      
H 57190 65F L 
       
- 
      
- M CF 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
    
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
+ B+ Growth cardia 
  
78 
Selvasekaran 
     
H 1389 50M L 
       
+ 
      
+ M A 
       
+ 
       
- 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ AW thickening;ascitis 
79 
Selvi 
      
H 
13947 37F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ Antrum thickening 
80 
Rabiya 
      
M 48519 65F L 
       
- 
      
- M A 
       
+ 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ PAW thickening;LS 
81 
Aadhinachiar 
      
H 16649 55F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ Pylorus growth 
82 
Poornam 
      
H 39569 40F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ AW thickening 
83 
Muthulakshmi 
      
H 31290 47F L 
       
- 
      
- M A 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
     
- 
       
- 
        
- 
       
- A+ Growth pyloric antrum 
84 
Karupasamy 
      
H 
56850 75M L 
       
- 
      
- M F 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ 
Growth fundus 
extending upto OGJ 
with ascitis 
85 
Kanagaraj 
      
H 
45537 58M L 
       
+ 
      
+ M P 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
      
- 
        
- 
       
- A+ NS 
86 
Chellammal 
      
H 
14048 44F L 
       
- 
      
- M A 
    
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- B+ LS; AW thickening 
87 
Saraswathi 
      
H 17481 45F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- AB+ 
Growth antrum with 
GOO 
88 
Subbiah 
      
H 8092 43M L 
       
- 
      
- M P 
       
- 
       
+ 
       
- 
       
- 
      
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A- Growth pylorus 
89 
Rajammal 
      
H 4398 60F L 
       
- 
      
- M P 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- AB+ AW thickening 
90 
Petchiammal 
      
H 57476 47F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
+ 
       
+ A+ LS 
91 
Neela 
      
H 25442 60F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ AW thickening 
92 
Annababu 
      
H 
50670 50F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Growth antrum 
  
93 
Sudalaimadi 
      
H 3758 45F L 
       
- 
      
- M A 
       
+ 
     
+ 
       
- 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
        
- 
       
- O+ Pyloric growth 
94 
Angammal 
    
H 38554 41F L 
       
- 
      
- M P 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ AW thickening 
95 
Guruvammal 
      
H 56294 75F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Growth antrum 
96 
Chellammal 
      
H 50038 55F L 
       
- 
      
- M OG 
       
- 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
- 
       
- A+ 
Growth C and F 
extending to OGJ 
97 
Soma sundaram 
      
H 43282 61M L 
       
+ 
      
+ M P 
       
+ 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- A+ Pyloric growth 
98 
Balammal 
      
H 54680 52F L 
       
- 
      
- M A 
       
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
        
- 
       
- O+ Ascitis 
99 
Thavasirajan 
      
H 35103 60M L 
       
- 
      
- M A 
       
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O+ AW thickening 
100 
Esakki 
      
H 36288 40M L 
       
- 
      
- M A 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
    
- 
       
- 
       
- 
       
- 
        
- 
       
+ A+ AW growth 
101 
Kaveri 
      
H  48535 55M L 
       
- 
      
- M P 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
+ 
   
+ 
       
- 
       
- 
       
- 
       
+ 
       
+ 
       
- 
        
- 
       
- A+ Antral growth 
102 
Ramaiah 
      
H 5863 70M L 
       
- 
      
- M P 
       
+ 
      
+ 
       
+ 
       
- 
       
+ 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
- 
        
- 
       
- O- Growth antrum 
103 
Palpandi 
      
H 10046 85M L 
       
- 
      
- M P 
       
+ 
       
+ 
       
+ 
       
- 
       
+ 
       
- 
       
+ 
       
- 
       
- 
       
- 
       
- 
       
+ 
       
+ 
        
+ 
       
- O- Growth antrum 
 
 
 
